These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16540657)

  • 21. Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.
    Perabo FG; Demant AW; Wirger A; Schmidt DH; Sitia M; Wardelmann E; Müller SC; Kohn EC
    Anticancer Res; 2005; 25(2A):725-9. PubMed ID: 15868902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
    Lokeshwar VB; Cerwinka WH; Lokeshwar BL
    Cancer Res; 2005 Mar; 65(6):2243-50. PubMed ID: 15781637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression.
    Chen SC; Henry DO; Hicks DG; Reczek PR; Wong MK
    J Urol; 2009 Jan; 181(1):336-42. PubMed ID: 19010488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
    Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
    Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro effect of paclitaxel on a LacZ-transfected malignant transitional cell line.
    Vatne V; Litlekalsoey J; Wentzel-Larsen T; Hostmark J
    Anticancer Res; 2005; 25(3B):2097-104. PubMed ID: 16158950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
    Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
    Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
    Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
    Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Animal experiment aspects of bladder cancer].
    Recker F; Otto T
    Urologe A; 1991 May; 30(3):172-9. PubMed ID: 1871936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
    Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
    Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial.
    Black PC; Dinney CP
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):623-34. PubMed ID: 17726580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
    Weiss C; Wolze C; Engehausen DG; Ott OJ; Krause FS; Schrott KM; Dunst J; Sauer R; Rödel C
    J Clin Oncol; 2006 May; 24(15):2318-24. PubMed ID: 16710030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Establishment of epithelial cell line TBC-27 from a human bladder transitional cell carcinoma and its biological characteristics].
    Liu CJ; Ma TX; Wang ZQ; Chang JW; Liu XB; Sui ZF; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):427-9, 21. PubMed ID: 3452540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.